Tatva Chintan's Q1 Surprise pushed the company's shares up by 18% on strong first-quarter earnings. Tatva Chintan gained 18.13% to Rs 1,687 after reporting sharp growth in profit and revenue.
India has taken a major step in fighting Dengue Vaccine after the country's first vaccine received approval. The approval marks a key moment for public health.
COVID Alert has returned to the spotlight after fresh Maharashtra COVID cases were reported nearly three years after infections remained low.
People with type 2 diabetes face a higher severe dengue risk, according to a new study. Researchers found the condition can increase the chances of dangerous dengue complications.
The US Cancer Market has moved a step closer for Alembic Pharma and Natco Pharma after the companies secured a key regulatory milestone.
Novo Nordisk’s Wegovy gains CDSCO approval for MASH in India, marking a key GLP-1 expansion into liver disease, strengthening its role in metabolic disorder treatment.
A wave of strategic deals, policy momentum, and technological breakthroughs defined the week for India’s drug manufacturers
A recent drug recall involving oncology products has once again brought global pharmaceutical quality standards into focus, recalls are not necessarily indicators of systemic failure but rather evidence of active monitoring and corrective mechanisms
The suspension of Premarin vaginal cream by Pfizer has drawn attention for its immediate impact, and also signals in evolving priorities in the Indian market
Merck’s cholesterol pill is poised to reshape the global cardiovascular drug landscape, this comes with the latest approval from the U.S. Food and Drug Administration for its first-in-class oral PCSK9 inhibitor
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")